News

Under the agreement, Oncothyreon will be responsible for funding and conducting the clinical development of ARRY-380 and will pay an upfront fee of $10m to Array. Phase 3

Administered using MannKind’s next-generation inhaler, the investigational, ultra rapid-acting mealtime insulin therapy is being developed against type 1 or type 2 diabetes to control hyperglycemia. All patients were

Topotecin intravenous drip infusion (irinotecan hydrochloride hydrate) is indicated for treatment of pancreatic cancer. Following discussions by the Review Committee for Unapproved or Off-label Use of Drugs with

Treatment with Votrient following front-line chemotherapy was found to reduce the risk of the disease progression or death by 23% in women with advanced epithelial ovarian cancer. While

Harvard University and Northeastern University collaborated on the development of the technology and jointly own the patent, while CryoXtract is the exclusive licensee. Protecting the frozen biological samples

Around $5m will be financed to Chimerix to initiate animal studies using the drug candidate over a period of 12 months to obtain clearance under the US Food

Niagen joins the portfolio of B-vitamin ingredients that are used in multi-vitamins, nutraceuticals, weight-loss, energy drinks, sports nutrition, meal replacements, and infant formula, food and beverage products. ChromaDex

Using the new system, which does not require any user interaction, an operator can just load a sample and choose a method, while the remaining activity is carried

In October 2012, the facility in Tamil Nadu was inspected and was found to have been breaching quality regulations during drugs manufacturing, as reported by Reuters. The regulator